COMPLETE TEST BANK FOR ADVANCED PHARMACOLOGY FOR PRESCRIBERS 1ST EDITION LUU KAYINGO TEST BANK |COMPLETE GUIDE A+|INSTANT DOWNLOAD EDITION
COMPLETE TEST BANK FOR ADVANCED PHARMACOLOGY FOR PRESCRIBERS 1ST EDITION LUU KAYINGO TEST BANK |COMPLETE GUIDE A+|INSTANT DOWNLOAD EDITION
COMPLETE TEST BANK FOR ADVANCED PHARMACOLOGY FOR PRESCRIBERS 1ST EDITION
LUU KAYINGO TEST BANK |COMPLETE GUIDE A+|INSTANT DOWNLOAD EDITION
,TABLE OF CONTENTS
CHAPTER 1: AN INTRODUCTION TO EVIDENCE-BASED CLINICAL PRACTICE GUIDELINES ...................... 3
CHAPTER 2: PHARMACOKINETICS......................................................................................................... 15
CHAPTER3: PHARMACODYNAMICS ...................................................................................................... 15
CHAPTER4: PHARMACOGENETICS AND PHARMACOGENOMICS ......................................................... 27
CHAPTER 5: PHARMACOLOGY ACROSS THE LIFE SPAN ........................................................................ 32
CHAPTER 6: DRUG-THERAPY PRESCRIBING IN SPECIAL POPULATIONS ................................................ 39
CHAPTER 7: DRUG DEVELOPMENT AND APPROVAL ............................................................................ 46
CHAPTER 8-: FOUNDATIONS OF PRESCRIPTION WRITING.................................................................... 52
CHAPTER 9: RESPONSIBLE CONTROLLED-SUBSTANCE PRESCRIBING ................................................... 52
CHAPTER 10: ANTIBIOTIC STEWARDSHIP ............................................................................................. 52
CHAPTER 11: APPLIED CALCULATIONS FOR PRESCRIBING ................................................................... 59
CHAPTER 12-: PROMOTING ADHERENCE WITH PHARMACOTHERAPY II: SYSTEM-SPECIfiC AND
PATIENT-FOCUSED PRESCRIBING.......................................................................................................... 68
CHAPTER 13: PHARMACOTHERAPY FOR EAR, NOSE, MOUTH, AND THROAT CONDITIONS ................ 68
CHAPTER 14: PHARMACOTHERAPY FOR EYE CONDITIONS .................................................................. 68
CHAPTER 15: PHARMACOTHERAPY FOR SKIN CONDITIONS................................................................. 74
CHAPTER 16: PHARMACOTHERAPY FOR NEUROLOGIC CONDITIONS .................................................. 80
CHAPTER 17: PHARMACOTHERAPY FOR CARDIOVASCULAR CONDITIONS .......................................... 93
CHAPTER 18: PHARMACOTHERAPY FOR RESPIRATORY CONDITIONS ................................................ 103
CHAPTER 19: PHARMACOTHERAPY FOR GASTROINTESTINAL CONDITIONS AND CONDITIONS
REQUIRING NUTRITIONAL SUPPORT .................................................................................................. 113
CHAPTER 20: PHARMACOTHERAPY FOR GENITOURINARY CONDITIONS ........................................... 123
CHAPTER 21: PHARMACOTHERAPY FOR RENAL, ACID–BASE, FLUID, AND ELECTROLYTE DISORDERS
............................................................................................................................................................ 128
CHAPTER 22: PHARMACOTHERAPY FOR MUSCULOSKELETAL AND RHEUMATOLOGIC CONDITIONS 141
CHAPTER 23: THERAPEUTIC APPLICATIONS OF IMMUNOLOGY AND VACCINES ................................ 151
CHAPTER 24: PHARMACOTHERAPY FOR ENDOCRINE DISORDERS ..................................................... 156
CHAPTER 25: PHARMACOTHERAPY FOR HEMATOLOGIC DISORDERS ................................................ 167
CHAPTER 26: HEMATOLOGY/ONCOLOGY AND SUPPORTIVE CARE FOR THE NONONCOLOGIST....... 182
CHAPTER 27: PHARMACOTHERAPY RELATED TO WOMEN’S HEALTH CONDITIONS .......................... 188
CHAPTER 28: PHARMACOTHERAPY RELATED TO MEN’S HEALTH CONDITIONS ................................ 200
CHAPTER 29: PHARMACOTHERAPY RELATED TO TRANSGENDER CARE............................................. 206
CHAPTER 30: ANTIMICROBIAL PHARMACOTHERAPY ......................................................................... 212
CHAPTER 31: ANTIRETROVIRAL PHARMACOTHERAPY ....................................................................... 222
CHAPTER 32: PSYCHOPHARMACOLOGY AND INTEGRATIVE HEALTH: COMBINED TREATMENT OF
PSYCHIATRIC AND NEUROCOGNITIVE CONDITIONS ........................................................................... 232
,CHAPTER 33: PHARMACOTHERAPY FOR PAIN MANAGEMENT .......................................................... 243
CHAPTER 34: SUBSTANCE USE DISORDER III: HEALTH PROMOTION AND MAINTENANCE ................ 252
CHAPTER 35: OVER-THE-COUNTER MEDICATIONS............................................................................. 268
CHAPTER 36: PHARMACOTHERAPY FOR OBESITY .............................................................................. 276
CHAPTER 1: AN INTRODUCTION TO EVIDENCE-BASED CLINICAL
PRACTICE GUIDELINES
MULTIPLE CHOICE
• WHAT IS THE PRIMARY PURPOSE OF THE NURSING ASSESSMENT?
• IDENTIFYING UNDERLYING PATHOLOGIC CONDITIONS
• ASSISTING THE PHYSICIAN IN IDENTIFYING MEDICAL CONDITIONS
• DETERMINING THE PATIENTS MENTAL STATUS
• EXPLORING PATIENT RESPONSES TO HEALTH PROBLEMS
CORRECT ANS> D
A NURSING ASSESSMENT IS DONE TO IDENTIFY THE PATIENTS RESPONSE TO HEALTH PROBLEMS.
DURING THE NURSING ASSESSMENT PHASE, A COMPREHENSIVE INFORMATION BASE IS DEVELOPED
THROUGH A PHYSICAL EXAMINATION, NURSING HISTORY, MEDICATION HISTORY, AND
PROFESSIONAL OBSERVATION. IDENTIFYING UNDERLYING PATHOLOGIC CONDITIONS AND
ASSISTING THE PHYSICIAN IN IDENTIFYING MEDICAL CONDITIONS IS NOT PART OF THE NURSING
PROCESS. DETERMINING THE PATIENTS MENTAL STATUS IS ONE PART OF THE NURSING
ASSESSMENT, BUT IT IS NOT THE PRIMARY PURPOSE.
MSC: NCLEX CLIENT NEEDS CATEGORY: HEALTH PROMOTION AND MAINTENANCE
• WHAT IS THE BASIS OF THE NANDA I TAXONOMY?
, • FUNCTIONAL HEALTH PATTERNS
• HUMAN RESPONSE PATTERNS
• BASIC HUMAN NEEDS
• PATHOPHYSIOLOGIC NEEDS
CORRECT ANS> B
THE NANDA I TAXONOMY IDENTIfiES HUMAN RESPONSE PATTERNS. FUNCTIONAL COMPONENTS OF
HEALTH PATTERNS ARE LIMITED TO ACTIVITY, flUID VOLUME, NUTRITION, SELF CARE, AND SENSORY
PERCEPTION. BASIC HUMAN NEEDS COMPRISE LESS THAN MERELY HEALTH PATTERNS.
PATHOPHYSIOLOGIC NEEDS ARE NOT PART OF THE SCOPE OF NANDA I.
DIF: COGNITIVE LEVEL: KNOWLEDGE REF: PP. 37-38 OBJ: 5 TOP:
• WHICH TASK IS INCLUDED IN THE ASSESSMENT STEP OF THE NURSING PROCESS?
• ESTABLISHING PATIENT GOALS/OUTCOMES
• IMPLEMENTING THE NURSING CARE PLAN (NCP)
• MEASURING GOAL/OUTCOME ACHIEVEMENT
• COLLECTING AND COMMUNICATING DATA
CORRECT ANS> D
DATA ARE COLLECTED AND COMMUNICATED IN THE ASSESSMENT PHASE OF THE NURSING
PROCESS. ESTABLISHING GOALS IS THE FUNCTION OF PLANNING.
IMPLEMENTING THE NCP IS THE FUNCTION OF IMPLEMENTATION. MEASURING OUTCOME
ACHIEVEMENT IS THE FUNCTION OF EVALUATION.
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller TONNIEEXCELL01. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $15.00. You're not tied to anything after your purchase.
